en
Scientific article
English

Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model

Published inBasic & clinical pharmacology & toxicology, vol. 113, no. 4, p. 259-265
Publication date2013
Abstract

Vitamin K antagonists (VKAs) are prescribed worldwide and remain the oral anticoagulant of choice. These drugs are characterized by a narrow therapeutic index and a large inter- and intra-individual variability. P-glycoprotein could contribute to this variability. The aim of this study was to investigate the involvement of P-gp in the transport of acenocoumarol, phenprocoumon and warfarin using an in vitro Caco-2 cell monolayer model. These results were compared with those obtained with rivaroxaban, a new oral anticoagulant known to be a P-gp substrate. The transport of these four drugs was assessed at pH conditions 6.8/7.4 in the presence or absence of the P-gp inhibitor cyclosporine A (10 μM) and the more potent and specific P-gp inhibitor valspodar (5 μM). Analytical quantification was performed by LC/MS. With an efflux ratio of 1.7 and a significant decrease in the efflux (Papp B-A), in the presence of P-gp inhibitors at a concentration of 50 μM, acenocoumarol can be considered as a weak P-gp substrate. Concerning phenprocoumon, the results suggest that this molecule is a poor P-gp substrate. The P-gp inhibitors did not affect significantly the transport of warfarin. The efflux of rivaroxaban was strongly inhibited by the two P-gp inhibitors. In conclusion, none of the three VKAs tested are strong P-gp substrates. However, acenocoumarol can be considered as a weak P-gp substrate and phenprocoumon as a poor P-gp substrate.

Keywords
  • Acenocoumarol/pharmacokinetics
  • Anticoagulants/pharmacokinetics
  • Biological Transport
  • Caco-2 Cells
  • Humans
  • Microscopy, Electron, Transmission
  • Morpholines/pharmacokinetics
  • P-Glycoprotein/metabolism
  • Thiophenes/pharmacokinetics
  • Vitamin K/antagonists & inhibitors/pharmacokinetics
  • Warfarin/pharmacokinetics
Citation (ISO format)
GSCHWIND, Liliane et al. Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model. In: Basic & clinical pharmacology & toxicology, 2013, vol. 113, n° 4, p. 259–265. doi: 10.1111/bcpt.12084
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1742-7835
514views
3downloads

Technical informations

Creation11/18/2014 4:12:00 PM
First validation11/18/2014 4:12:00 PM
Update time03/14/2023 10:27:58 PM
Status update03/14/2023 10:27:57 PM
Last indexation01/16/2024 3:14:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack